Astera Labs (ALAB) Stock Forecast & Price Target

$137.93 +6.83 (+5.21%)

Closing price 04:00 PM Eastern

Extended Trading

$139.48 +1.55 (+1.12%)

As of 07:59 PM Eastern

Astera Labs - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 17 Analyst Ratings

Sell
0

Hold
3

Buy
14

Based on 17 Wall Street analysts who have issued ratings for Astera Labs in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 3 have given a hold rating, and 14 have given a buy rating for ALAB.

Consensus Price Target

$106.73
-22.62% Downside

According to the 17 analysts' twelve-month price targets for Astera Labs, the average price target is $106.73. The highest price target for ALAB is $145.00, while the lowest price target for ALAB is $75.00. The average price target represents a forecasted downside of -22.62% from the current price of $137.93.

Get the Latest News and Ratings for ALAB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Astera Labs and its competitors.

ALAB Analyst Ratings Over Time

Type	Current Forecast 8/4/24 to 8/4/25	1 Month Ago 7/5/24 to 7/5/25	3 Months Ago 5/6/24 to 5/6/25	1 Year Ago 8/5/23 to 8/4/24
Strong Buy	0 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	14 Buy rating(s)	11 Buy rating(s)	11 Buy rating(s)
Hold	3 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$106.73	$100.00	$109.25	$86.09
Forecasted Upside	-22.62% Downside	9.98% Upside	52.72% Upside	103.14% Upside
Consensus Rating	Moderate Buy	Buy	Buy	Buy

ALAB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ALAB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Astera Labs Stock vs. The Competition

Type	Astera Labs	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.82	2.66	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	-22.62% Downside	67.93% Upside	13.14% Upside
News Sentiment Rating	Positive News See Recent ALAB News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/4/2025	Stifel Nicolaus 4 of 5 stars	Tore Svanberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$110.00 ➝ $145.00	+2.43%
7/30/2025	Morgan Stanley 3 of 5 stars	Joseph Moore Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$99.00 ➝ $125.00	+5.57%
7/22/2025	Northland Capmk 0 of 5 stars		Downgrade	Strong-Buy ➝ Hold
7/22/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$95.00 ➝ $130.00	+11.20%
7/22/2025	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform	$120.00	-1.55%
5/22/2025	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sebastien Naji Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
5/21/2025	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lipacis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$87.00 ➝ $104.00	+10.51%
5/16/2025	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mehdi Hosseini Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$80.00	-11.15%
5/7/2025	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Suji Desilva Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target	Buy ➝ Buy	$100.00	+40.40%
5/7/2025	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Quinn Bolton Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$140.00 ➝ $100.00	+39.79%
Get the Latest News and Ratings for ALAB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Astera Labs and its competitors with MarketBeat's FREE daily newsletter.
5/7/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tom O'Malley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$70.00 ➝ $75.00	+4.84%
4/14/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Malik Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$120.00 ➝ $100.00	+67.31%
3/14/2025	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Srini Pajjuri Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$82.00	+25.54%
2/11/2025	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Shannon Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$105.00 ➝ $125.00	+29.86%
11/5/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$80.00 ➝ $105.00	+10.10%
11/5/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$70.00 ➝ $110.00	+20.13%
11/5/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$60.00 ➝ $100.00	+11.92%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:07 PM ET.

ALAB Forecast - Frequently Asked Questions

: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Astera Labs is $106.73, with a high forecast of $145.00 and a low forecast of $75.00.
: 17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Astera Labs in the last twelve months. There are currently 3 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALAB shares.
: According to analysts, Astera Labs's stock has a predicted downside of -22.62% based on their 12-month stock forecasts.
: Over the previous 90 days, Astera Labs's stock had 2 downgrades and 1 upgrade by analysts.
: Astera Labs has been rated by research analysts at Barclays, Evercore ISI, Jefferies Financial Group, Morgan Stanley, Needham & Company LLC, Northland Capmk, Northland Securities, Roth Capital, Stifel Nicolaus, Susquehanna, and William Blair in the past 90 days.
: Analysts like Astera Labs more than other "computer and technology" companies. The consensus rating score for Astera Labs is 2.82 while the average consensus rating score for "computer and technology" companies is 2.66. Learn more on how ALAB compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:ALAB) was last updated on 8/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Astera Labs (ALAB) Stock Forecast & Price Target